Is Empa Gliplose a Risk Enhancer for Cardiovascular Disease?

JAMA Medical News Associate Managing Editor Jennifer Abbasi talks with Manesh Patel, MD, about the latest trials and topics from the American Heart Association’s Scientific Sessions meeting. Patel is chief of the division of cardiology at Duke University School of Medicine and this year’s Scientific Sessions conference chair.

Related Content:

• Association of Apolipoprotein B–Containing Lipoproteins and Risk of Myocardial Infarction in Individuals With and Without Atherosclerosis
• Highlights From the American Heart Association’s Scientific Sessions—ApoB as a Risk Marker, an Oral PCSK9 Inhibitor, Aspirin and Dementia, and More

Authors have declared conflicts of interest related to the article discussed in this podcast. Visit the article on jama.com for the complete disclosure.